• / Free eNewsletters & Magazine
  • / My Account
Home>Mallinckrodt agrees to buy Ikaria in $2.3 billion deal

Mallinckrodt agrees to buy Ikaria in $2.3 billion deal

3party Content

Thu, 5 Mar 2015

Specialty drugs company Mallinckrodt plc (MNK) said Thursday it has agreed to buy privately-held critical care company Ikaria Inc. from an investor group led by private-equity firm Madison Dearborn, in a deal valued at about $2.3 billion. The company said it expects the deal to close in the second
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.